1-1 of 1
Alessandra Ferrajolil, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Clofarabine Plus Idarubicin and Clofarabine Plus Idarubicin Plus Cytarabine (ARA-C) in Patients (PTS) with Relapsed and Primary Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myeloid Blast Phase of Chronic Myeloid Leukemia (CML).

Stefan Faderl, MD, Alessandra Ferrajolil, MD, William Wierda, MD PhD, Srdan Verstovsek, MD, PhD, Farhad Ravandi-Kashani, MD, Guillermo Garcia-Manero, MD, Elihu Estey, MD, Deborah A. Thomas, MD, Steve Kornblau, MD, Monica Kwari, RN, Varsha Gandhi, PhD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2004) 104 (11): 1809.
https://doi.org/10.1182/blood.V104.11.1809.1809
Published: 2004